Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Series A Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Stock Notes Receivable From Employees
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2019   0 39,153,195        
Beginning Balance at Dec. 31, 2019 $ 494,874,000 $ 0 $ 4,000 $ 104,658,000 $ (4,000) $ 388,238,000 $ 1,978,000
Net and comprehensive income (loss) 43,434,000         42,838,000 596,000
Stock-based compensation 9,905,000     9,905,000      
Issuance of common stock pursuant to employee stock purchase plan (in shares)     27,596        
Issuance of common stock pursuant to employee stock purchase plan 642,000     642,000      
Issuance of common stock for vesting of restricted stock units (in shares)     264,235        
Issuance of common stock for unvested restricted stock awards (in shares)     19,516        
Shares withheld related to net share settlement of stock-based awards (in shares)     (62,566)        
Issuance of common stock for stock settled deferred consideration (2,023,000)     (2,023,000)      
Reduction of stock notes receivable from employees 4,000       4,000    
Ending Balance (in shares) at Dec. 31, 2020   0 39,401,976        
Ending Balance at Dec. 31, 2020 546,836,000 $ 0 $ 4,000 113,182,000 0 431,076,000 2,574,000
Net and comprehensive income (loss) 140,806,000         142,470,000 (1,664,000)
Stock-based compensation 10,361,000     10,361,000      
Issuance of common stock pursuant to employee stock purchase plan (in shares)     20,152        
Issuance of common stock pursuant to employee stock purchase plan 653,000     653,000      
Issuance of common stock for settlement of deferred stock units (in shares)     60,373        
Issuance of common stock for vesting of restricted stock units (in shares)     260,525        
Issuance of common stock for unvested restricted stock awards (in shares)     13,323        
Issuance of common stock for stock settled deferred consideration (in shares)     27,481        
Shares withheld related to net share settlement of stock-based awards 1,000,000     1,000,000      
Shares withheld related to net share settlement of stock-based awards (in shares)     (91,457)        
Issuance of common stock for stock settled deferred consideration (3,352,000)     (3,352,000)      
Ending Balance (in shares) at Dec. 31, 2021   0 39,692,373        
Ending Balance at Dec. 31, 2021 696,304,000 $ 0 $ 4,000 121,844,000 0 573,546,000 910,000
Net and comprehensive income (loss) 99,698,000         104,225,000 (4,527,000)
Dividends, Common Stock (62,572,000)         (62,572,000)  
Stock-based compensation 17,312,000     17,312,000      
Issuance of common stock pursuant to employee stock purchase plan (in shares)     19,813        
Issuance of common stock pursuant to employee stock purchase plan 709,000     709,000      
Issuance of common stock for settlement of deferred stock units (in shares)     281,193        
Issuance of common stock for vesting of restricted stock units (in shares)     292,953        
Issuance of common stock for unvested restricted stock awards (in shares)     11,494        
Issuance of common stock for stock settled deferred consideration (in shares)     28,673        
Shares withheld related to net share settlement of stock-based awards 1,417,000     1,417,000      
Shares withheld related to net share settlement of stock-based awards (in shares)     (206,390)        
Issuance of common stock for stock settled deferred consideration (9,741,000)     (9,741,000)      
Repurchases of common stock (29,618,000)   $ (864,000)     (29,618,000)  
Ending Balance (in shares) at Dec. 31, 2022   0 39,255,838        
Ending Balance at Dec. 31, 2022 $ 713,509,000 $ 0 $ 4,000 $ 131,541,000 $ 0 $ 585,581,000 $ (3,617,000)